
B. Riley lowered the firm’s price target on Precigen (PGEN) to $11 from $12 and keeps a Buy rating on the shares. Precigen reached positive cash flow ahead of schedule,
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| PGEN | Precigen | 4.26 | 0.27 | 6.67% |
| Name | Price | % Change | |
|---|---|---|---|
| $4.26 | +6.67% |

B. Riley lowered the firm’s price target on Precigen (PGEN) to $11 from $12 and keeps a Buy rating on the shares. Precigen reached positive cash flow ahead of schedule,

Precigen, Inc. (($PGEN)) has held its Q3 earnings call. Read on for the main highlights of the call. Precigen delivered a strongly positive third-quarter earnings call, led by rapid PAPZIMEOS

Piper Sandler lowered the firm’s price target on Inovio (INO) to $6 from $8 and keeps an Overweight rating on the shares. The firm notes the company ended Q3 with

Citizens raised the firm’s price target on Precigen (PGEN) to $12 from $11 and keeps an Outperform rating on the shares. Precigen posted another “stellar” quarter for Papzimeos and robust

Reports Q3 revenue $72.96M, consensus $71.56M. “Precigen (PGEN) has established an exceptional position of strength, with commercial momentum and a proven strategy driving our next phase of growth,” said CEO

Pre-earnings options volume in Precigen (PGEN) is 1.7x normal with calls leading puts 19:2. Implied volatility suggests the market is anticipating a move near 11.5%, or 0c, after results are

Analyst Swayampakula Ramakanth of H.C. Wainwright reiterated a Buy rating on Precigen, retaining the price target of $18.00. Swayampakula Ramakanth’s rating is based on several factors supporting Precigen’s commercial momentum.

Precigen (PGEN) is down -23.6%, or -$1.64 to $5.30. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on

Precigen (PGEN) is down -26.5%, or -$1.84 to $5.10. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on

Shares of Precigen (PGEN) (PCGN) are down 27% to $5.05 in early trading after Inovio’s (INO) competing recurrent respiratory papillomatosis received FDA approval. Published first on TheFly – the ultimate
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| Mar 2, 2027TBA | $1.49B | $0.11 | $87.89M | -0.01 | 60.91 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.